HOME >> BIOLOGY >> NEWS
Report calls for improved monoclonal antibodies against solid tumors

A new report by leading experts in monoclonal antibody research for oncology offers a conceptual framework for future research in the design of antibody therapies against solid tumors. Writing in the January 15, 2007 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, the researchers note that 85 percent of cancers involve solid tumors, but only 25 percent of approved antibody therapies are directed at solid tumor targets. The researchers suggest manipulation of the physical properties of a monoclonal antibody as a potentially effective way to improve antibody treatments for solid tumors.

Monoclonal antibodies ability to target a single specific protein on cancer cells, has led to their being called a magic bullet that targets only cancer cells while minimizing collateral damage to healthy tissue. That damage causes the toxicity associated with chemotherapy and radiation therapy. In the nearly 20 years since scientists were able to create monoclonal antibodies that could be safely used in humans, eight monoclonal antibodies have been approved for use in clinical treatments to trigger immune responses to cancer cells, modulate cancer cell growth, and deliver drugs to cancer cells. Of these, only three are used on solid tumors. However, solid tumors account for 85 percent of all cancers.

According to review lead author Robert A. Beckman, M.D. of the Department of Clinical Hematology and Oncology at Centocor Research & Development, Inc. in Malvern, PA and his co-authors, Louis M. Weiner, M.D. of Fox Chase Cancer Center in Philadelphia and Hugh M. Davis, Ph.D. of the Department of Clinical Pharmacology and Experimental Medicine at Centocor, a major difficulty in developing monoclonal antibody treatments for solid tumors has been their ability to penetrate the tumor. To be effective, the treatment must gain acce
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
11-Dec-2006


Page: 1 2

Related biology news :

1. Report recommends off-site disposal of secondary waste
2. SNM initiatives supported by inclusions in NAS Report on competitiveness of US chemistry research
3. AAAS/EurekAlert! refocus on China with 2007 Fellowships for Science Reporters in Developing Regions
4. Report outlines funding to conserve half of Massachusettss land
5. Report challenges common ecological hypothesis about species abundance
6. Report highlights change in Canadas forests
7. Report: Canadas Yellowstone too small for wildlife
8. Report warns about carbon dioxide threats to marine life
9. Report focuses on the role good microbes play in future medicine
10. Herringtons annual 2006 State of the Shore Report, May 22
11. Report finds cruise industry is protecting the precious places it visits

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... (PRWEB) , ... March 04, 2020 , ... ... supplements, today announced the release of a unique, multi-dimensional nutraceutical formula for ocular ... published science and natural plant biology to increase the retina’s healthy pigmentation and ...
(Date:3/3/2020)... Calif. (PRWEB) , ... March 03, 2020 , ... Amplify ... levels with the dualX Expanding Interbody Fusion System. , The landmark case ... CA. After the case Dr. Najafi noted, “dualX has completely changed the game ...
(Date:3/2/2020)... , ... March 02, 2020 , ... Nominations are now ... co-founded by the Security Industry Association (SIA) and SecureIDNews and ... Women in Security Forum . The recipients of this year’s Women in Biometrics Awards ...
Breaking Biology News(10 mins):
(Date:2/28/2020)... ... 2020 , ... Designed primarily for laboratory and industrial use, ... thus simplifying setup, streamlining integration, and optimizing workflow. Capable of recording FHD (1080p) ... new HS Series cameras to be released. The HS Series includes cameras with ...
(Date:2/21/2020)... ... 2020 , ... In a free session on Tuesday, March 10, ... Lisa Dilworth, BS, MS, Vice President Rare, Orphan and Pediatric Diseases, and Rachael Young, ... to support patients, sites and sponsors. , When planning a rare disease clinical trial, ...
(Date:2/21/2020)... ... February 20, 2020 , ... The dietary supplement industry ... that what’s listed on an ingredient panel is actually in their product. ... with the adoption of CertainT, which is designed to protect the intellectual property ...
(Date:2/21/2020)... TORONTO (PRWEB) , ... February 21, 2020 , ... ... innovation to improve their manufacturing operations in order to adapt to new approaches ... keep up with the increasing demand for personalized medicine and therapies. But with ...
Breaking Biology Technology:
Cached News: